3,5-dimethyladamantane-1-carboxylic acid, 95.0%, 250mg

3-Bromo-4-methoxyphenylacetonitrile, 98.0%, 25g

1,4-Diformylpiperazine25g

Bencilamina, min 99%, para síntesis, 1L, envase de vidrio

3,4,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrrolo[1,2-a]pyrazin-1(7H)-one, 98%, 1g

3-Chloro-2-fluorobenzoic acid, 99.8%, 10g

tert-Butyl 4-[2-(aminomethyl)phenyl]piperazine-1-carboxylate, 95+%, 100mg

[1-(Hydroxymethyl)cyclopropyl]acetonitrile, 94.0%, 500mg

3-Isopropylpiperazine-2,5-dione, 95.0%, 1g

2-(4-Fluorophenyl)ethylamine>98.0%(GC)(T)25g

alpha-Bromophenylacetic Acid>98.0%(GC)(T)25g

(R)-tert-Butyl 2-(hydroxymethyl)-1,4-oxazepane-4-carboxylate, 97%, 100mg

2,4-Dichloro-6-cyclopropyl-pyrimidine, 97.0%, 1g